| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.9 |